RT @DiabetologiaJnl: DOC2B promotes #insulinsensitivity in mice via a novel #KinesinLightChain1 (KLC1)-dependent mechanism in #SkeletalMusc…
DOC2B promotes #insulinsensitivity in mice via a novel #KinesinLightChain1 (KLC1)-dependent mechanism in #SkeletalMuscle. @Cityofhope @AmericanHeartLA https://t.co/MEfqrMxkTP #toptweet https://t.co/QauMNj0Jd8
RT @DiabetologiaJnl: DOC2B promotes #insulinsensitivity in mice via a novel #KinesinLightChain1 (KLC1)-dependent mechanism in #SkeletalMusc…
DOC2B promotes #insulinsensitivity in mice via a novel #KinesinLightChain1 (KLC1)-dependent mechanism in #SkeletalMuscle. @Cityofhope @AmericanHeartLA https://t.co/MEfqrMxkTP https://t.co/JXCuy9A93j
RT @DanielJDrucker: Skeletal muscle #insulin resistance. Such an attractive yet elusive (and perhaps outdated?) target #T2D Here DOC2B as a…
RT @DanielJDrucker: Skeletal muscle #insulin resistance. Such an attractive yet elusive (and perhaps outdated?) target #T2D Here DOC2B as a…
RT @DanielJDrucker: Skeletal muscle #insulin resistance. Such an attractive yet elusive (and perhaps outdated?) target #T2D Here DOC2B as a…
Skeletal muscle #insulin resistance. Such an attractive yet elusive (and perhaps outdated?) target #T2D Here DOC2B as a novel drug target in the muscle to prevent/treat type 2 #diabetes https://t.co/WRtSyrsHrm